News Medical on MSN1d
Anthraquinone compound Kanglexin investigated for treatment of atherosclerosisAtherosclerosis, a disease characterized by the accumulation of lipids and inflammatory cells in the arterial wall, is a ...
Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.
On January 29, 2025, the U.S. Court of Appeals for the Federal Circuit affirmed the grant of a preliminary injunction by the Northern District of ...
A research team has revealed that cadmium, a toxic heavy metal, increases the synthesis of hyaluronan in vascular endothelial ...
Peptides have emerged as a fascinating class of biomolecules with multifaceted roles across biological systems. Vesugen, a ...
Susvimo is indicated for intravitreal use via the Susvimo eye implant only. Ranibizumab is a vascular endothelial growth ...
News Medical on MSN7d
Low vitamin D in first trimester linked to higher preterm birth risk and reduced fetal lengthMaternal vitamin D status in early pregnancy is crucial for fetal growth and may reduce the risk of preterm birth, according ...
A dual-responsive hydrogel offers a breakthrough in osteoarthritis treatment by inhibiting neurovascularization and reducing ...
A research team led by Prof. WENG Jianping from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS) revealed that insulin-like growth factor-binding ...
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback